Single inhaler as maintenance and reliever therapy--is it SMART?

Affiliations

Comment

René Aalbers. Lancet Respir Med. 2013 Mar.

. 2013 Mar;1(1):2-3.

doi: 10.1016/S2213-2600(13)70020-1. Epub 2013 Mar 4.

¹ Martini Hospital, Groningen 9700 RM, Netherlands. Electronic address: longleven@hotmail.com.

No abstract available

Comment on

Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
Papi A, Corradi M, Pigeon-Francisco C, Baronio R, Siergiejko Z, Petruzzelli S, Fabbri LM, Rabe KF. Papi A, et al. Lancet Respir Med. 2013 Mar;1(1):23-31. doi: 10.1016/S2213-2600(13)70012-2. Epub 2013 Mar 4. Lancet Respir Med. 2013. PMID: 24321801 Clinical Trial.
Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
Patel M, Pilcher J, Pritchard A, Perrin K, Travers J, Shaw D, Holt S, Harwood M, Black P, Weatherall M, Beasley R; SMART Study Group. Patel M, et al. Lancet Respir Med. 2013 Mar;1(1):32-42. doi: 10.1016/S2213-2600(13)70007-9. Epub 2013 Mar 4. Lancet Respir Med. 2013. PMID: 24321802 Clinical Trial.